Dr. Deepak Cyril D'Souza (Yale University School of Medicine) joins the podcast to discuss a study looking at two cohorts of patients hospitalized with first instances of psychosis, one with cannabis exposure and one without. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin takes us through the August issue of the Journal, which takes a look at issues surrounding schizophrenia spectrum disorder, from the clinical to basic science.

00:40 D'Souza interview
02:38 Subtyping and schizophrenia spectrum disorder
04:19 Relapse and long-term implications for cannabis induced psychosis
05:43 Improvements in cognition
08:03 Differences between the groups
09:26 Greater access and greater potency of cannabis products
11:29 Further research
13:45 Kalin interview
13:59 D'Souza et al.
21:34 Forsyth et al.
27:36 Enwright et al.

Transcript

Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it.

Subscribe to the podcast here.

Listen to other podcasts produced by the American Psychiatric Association.

Browse articles online.

How authors may submit their work.

Follow the journals of APA Publishing on Twitter.

E-mail us at ajp@psych.org

00:40 D'Souza interview
02:38 Subtyping and schizophrenia spectrum disorder
04:19 Relapse and long-term implications for cannabis induced psychosis
05:43 Improvements in cognition
08:03 Differences between the groups
09:26 Greater access and greater potency of cannabis products
11:29 Further research
13:45 Kalin interview
13:59 D'Souza et al.
21:34 Forsyth et al.
27:36 Enwright et al.